Hospital Mater DeiBSP:MATD3 -0.41%75 Buyback Yield % is 1.88 as of Jun. 28, 2026, which is 27% above its 10-year median of 1.48. GuruFocus rates BSP:MATD3 with a GF Score™ of 75/100 and a GF Value™ of R$2,813.62 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 79.34% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
Hospital Mater Dei Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a Buyback Yield % of 1.88 as of Jun. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hospital Mater Dei and its competitors. This is 27% above median its historical median of 1.48. According to the industry distribution chart, Hospital Mater Dei ranks #56 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 20.7%.
Is Hospital Mater Dei's Buyback Yield % too high?
Hospital Mater Dei's current Buyback Yield % of 1.88 is 27% above median its 10-year median of 1.48. Based on the distribution chart, Hospital Mater Dei ranks #56 out of 271 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #56 out of 271 companies for Buyback Yield %. This places Hospital Mater Dei in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hospital Mater Dei and its competitors. Hospital Mater Dei's current Buyback Yield % is 1.88, which is 27% above median its own 10-year median of 1.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Possible Value Trap. The stock's GF Value™ is R$2,813.62, compared to a current price of R$4.88 — trading 99.8% below its estimated fair value. The current Buyback Yield % is 1.88, which is 27% above median its 10-year median of 1.48. Hospital Mater Dei's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Buyback Yield % is 1.88 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.88 is trading 99.8% below its estimated GF Value™ of R$2,813.62.
GuruFocus considers Hospital Mater Dei to be Possible Value Trap.
Key valuation signals for BSP:MATD3:
Buyback Yield %: 1.88 (27% above median its 10-year median of 1.48)
GF Value™: R$2,813.62 vs. price of R$4.88 (99.8% below fair value)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
75GF Score
Get the complete analysis for BSP:MATD3
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
